Revelation Biosciences, Inc. (REVBW) operating KPIs

REVBWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVB

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 6/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $16.05MP/E –Yield –

KPIs

Operating metrics that drive Revelation Biosciences's business

Coming soon

This tab will track the numbers specific to Revelation Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.